Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 12 | 2024 | 2151 | 2.100 |
Why?
|
Uganda | 20 | 2024 | 1332 | 1.650 |
Why?
|
Hypothermia | 3 | 2024 | 188 | 1.600 |
Why?
|
Placenta Diseases | 2 | 2021 | 199 | 1.270 |
Why?
|
Placenta | 10 | 2023 | 1709 | 1.110 |
Why?
|
HIV Infections | 15 | 2024 | 17351 | 1.100 |
Why?
|
Prenatal Care | 2 | 2022 | 1139 | 0.910 |
Why?
|
Postpartum Period | 4 | 2024 | 1173 | 0.890 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2017 | 420 | 0.840 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2024 | 242 | 0.820 |
Why?
|
Maternal-Fetal Relations | 1 | 2021 | 25 | 0.790 |
Why?
|
Placentation | 1 | 2021 | 78 | 0.760 |
Why?
|
Tuberculosis, Meningeal | 1 | 2021 | 47 | 0.710 |
Why?
|
Maternal Mortality | 5 | 2023 | 302 | 0.710 |
Why?
|
Pregnancy | 27 | 2024 | 29874 | 0.670 |
Why?
|
Infant Mortality | 1 | 2024 | 759 | 0.660 |
Why?
|
Rural Population | 2 | 2020 | 2285 | 0.630 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 544 | 0.590 |
Why?
|
Nasopharynx | 1 | 2020 | 401 | 0.590 |
Why?
|
Acinetobacter | 1 | 2017 | 39 | 0.570 |
Why?
|
HIV-1 | 6 | 2020 | 6863 | 0.550 |
Why?
|
Gatekeeping | 1 | 2016 | 49 | 0.550 |
Why?
|
Fees, Pharmaceutical | 1 | 2016 | 66 | 0.550 |
Why?
|
Acinetobacter Infections | 1 | 2017 | 73 | 0.550 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2019 | 587 | 0.530 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 612 | 0.530 |
Why?
|
Cephalosporins | 1 | 2017 | 198 | 0.520 |
Why?
|
Drug Resistance, Microbial | 2 | 2019 | 825 | 0.520 |
Why?
|
Nasal Cavity | 2 | 2019 | 304 | 0.520 |
Why?
|
Cerebral Infarction | 1 | 2021 | 983 | 0.520 |
Why?
|
Pregnancy Outcome | 4 | 2021 | 2921 | 0.510 |
Why?
|
Marburg Virus Disease | 1 | 2015 | 11 | 0.510 |
Why?
|
Cytokines | 4 | 2024 | 7396 | 0.500 |
Why?
|
Ebolavirus | 2 | 2017 | 251 | 0.490 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 935 | 0.470 |
Why?
|
Carrier State | 2 | 2019 | 523 | 0.460 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2019 | 698 | 0.460 |
Why?
|
Lung | 3 | 2021 | 10000 | 0.430 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.430 |
Why?
|
Paenibacillus | 2 | 2023 | 16 | 0.400 |
Why?
|
Staphylococcal Infections | 2 | 2019 | 1408 | 0.380 |
Why?
|
Fluid Therapy | 1 | 2015 | 579 | 0.370 |
Why?
|
Hydrocephalus | 3 | 2023 | 764 | 0.370 |
Why?
|
Medically Uninsured | 1 | 2016 | 836 | 0.370 |
Why?
|
Stillbirth | 3 | 2023 | 368 | 0.340 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1914 | 0.340 |
Why?
|
Infant, Newborn | 10 | 2024 | 26198 | 0.310 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1458 | 0.310 |
Why?
|
Drug Utilization | 1 | 2014 | 1188 | 0.310 |
Why?
|
Health Resources | 1 | 2014 | 935 | 0.310 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1897 | 0.300 |
Why?
|
Genitalia, Female | 1 | 2008 | 147 | 0.290 |
Why?
|
Aftercare | 2 | 2023 | 914 | 0.270 |
Why?
|
CD4 Lymphocyte Count | 5 | 2018 | 2571 | 0.270 |
Why?
|
Fever | 4 | 2022 | 1618 | 0.270 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1022 | 0.270 |
Why?
|
Female | 38 | 2024 | 392644 | 0.260 |
Why?
|
Fetal Blood | 2 | 2024 | 1347 | 0.260 |
Why?
|
Mortality | 2 | 2019 | 2901 | 0.260 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3156 | 0.260 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7407 | 0.250 |
Why?
|
Blood | 1 | 2007 | 596 | 0.250 |
Why?
|
HIV | 2 | 2022 | 1582 | 0.240 |
Why?
|
Prospective Studies | 10 | 2024 | 54425 | 0.240 |
Why?
|
Occupational Exposure | 1 | 2015 | 1813 | 0.240 |
Why?
|
Apgar Score | 1 | 2024 | 126 | 0.230 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1302 | 0.230 |
Why?
|
Adult | 28 | 2024 | 221177 | 0.220 |
Why?
|
Humans | 48 | 2024 | 761504 | 0.220 |
Why?
|
Medicaid | 1 | 2016 | 2818 | 0.210 |
Why?
|
Dyspnea | 2 | 2021 | 1347 | 0.210 |
Why?
|
Gram-Negative Bacteria | 2 | 2021 | 272 | 0.200 |
Why?
|
Cesarean Section | 2 | 2021 | 1396 | 0.200 |
Why?
|
Diagnosis, Differential | 4 | 2021 | 12974 | 0.200 |
Why?
|
Tetanus Toxoid | 1 | 2022 | 189 | 0.200 |
Why?
|
Receptors, IgG | 2 | 2022 | 559 | 0.200 |
Why?
|
Malaria | 2 | 2010 | 1227 | 0.190 |
Why?
|
Meningitis | 1 | 2023 | 217 | 0.190 |
Why?
|
Lethargy | 1 | 2021 | 43 | 0.180 |
Why?
|
HIV Antibodies | 1 | 2007 | 1303 | 0.180 |
Why?
|
DNA, Viral | 1 | 2007 | 2202 | 0.180 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4527 | 0.180 |
Why?
|
Postnatal Care | 1 | 2022 | 262 | 0.180 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.170 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1351 | 0.170 |
Why?
|
Antigens, Viral | 2 | 2021 | 988 | 0.170 |
Why?
|
Premature Birth | 2 | 2023 | 1782 | 0.170 |
Why?
|
Immunoglobulin G | 2 | 2022 | 4544 | 0.170 |
Why?
|
Infant, Low Birth Weight | 1 | 2024 | 870 | 0.170 |
Why?
|
Viremia | 1 | 2022 | 707 | 0.170 |
Why?
|
Parity | 1 | 2022 | 927 | 0.160 |
Why?
|
Young Adult | 8 | 2024 | 59243 | 0.160 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2021 | 238 | 0.160 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 231 | 0.160 |
Why?
|
Colony Count, Microbial | 1 | 2019 | 330 | 0.160 |
Why?
|
Infant, Newborn, Diseases | 1 | 2024 | 589 | 0.160 |
Why?
|
Infant, Small for Gestational Age | 1 | 2021 | 461 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 461 | 0.150 |
Why?
|
Puerperal Infection | 1 | 2018 | 44 | 0.150 |
Why?
|
Sepsis | 2 | 2023 | 2585 | 0.150 |
Why?
|
Labor, Obstetric | 1 | 2021 | 323 | 0.150 |
Why?
|
Gestational Age | 2 | 2024 | 3577 | 0.150 |
Why?
|
Cross Infection | 2 | 2019 | 1422 | 0.150 |
Why?
|
Alanine | 1 | 2020 | 609 | 0.150 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 580 | 0.150 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2017 | 151 | 0.140 |
Why?
|
Viral Load | 3 | 2017 | 3332 | 0.140 |
Why?
|
Postpartum Hemorrhage | 1 | 2021 | 271 | 0.140 |
Why?
|
Africa, Western | 1 | 2017 | 159 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1078 | 0.140 |
Why?
|
Leukocyte Count | 1 | 2020 | 1596 | 0.140 |
Why?
|
Antibodies, Bacterial | 1 | 2022 | 1469 | 0.130 |
Why?
|
Temperature | 1 | 2022 | 2226 | 0.130 |
Why?
|
Vagina | 1 | 2021 | 838 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4369 | 0.130 |
Why?
|
Virus Diseases | 1 | 2021 | 718 | 0.130 |
Why?
|
General Practice | 1 | 2016 | 97 | 0.130 |
Why?
|
Maternal Health Services | 1 | 2021 | 461 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 831 | 0.120 |
Why?
|
Birth Weight | 1 | 2023 | 2103 | 0.120 |
Why?
|
Surgical Wound Infection | 2 | 2021 | 1527 | 0.120 |
Why?
|
Infant | 7 | 2024 | 36192 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1880 | 0.120 |
Why?
|
Infant, Premature | 1 | 2024 | 2107 | 0.120 |
Why?
|
Cohort Studies | 5 | 2020 | 41487 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 827 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1509 | 0.110 |
Why?
|
Brain | 1 | 2021 | 27112 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 787 | 0.110 |
Why?
|
Nose | 1 | 2017 | 521 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1779 | 0.110 |
Why?
|
Dexamethasone | 1 | 2020 | 1948 | 0.110 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2628 | 0.110 |
Why?
|
Cost Sharing | 1 | 2016 | 409 | 0.110 |
Why?
|
Patient Discharge | 2 | 2023 | 3443 | 0.100 |
Why?
|
Headache | 1 | 2021 | 1256 | 0.100 |
Why?
|
Uterine Cervicitis | 1 | 2012 | 31 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13380 | 0.100 |
Why?
|
Vaginitis | 1 | 2012 | 49 | 0.100 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 1784 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2019 | 1390 | 0.090 |
Why?
|
Logistic Models | 2 | 2024 | 13255 | 0.090 |
Why?
|
Potassium | 1 | 2015 | 1311 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1809 | 0.090 |
Why?
|
Disease Outbreaks | 2 | 2017 | 1749 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2093 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3492 | 0.090 |
Why?
|
Incidence | 3 | 2018 | 21353 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1459 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2199 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6075 | 0.090 |
Why?
|
Prevalence | 3 | 2021 | 15732 | 0.080 |
Why?
|
Male | 10 | 2024 | 360804 | 0.080 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 258 | 0.080 |
Why?
|
Adolescent | 6 | 2020 | 88319 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4227 | 0.080 |
Why?
|
Patient Readmission | 1 | 2023 | 3270 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8529 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2020 | 3060 | 0.080 |
Why?
|
Rwanda | 2 | 2021 | 665 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10552 | 0.070 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2008 | 411 | 0.070 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2008 | 239 | 0.070 |
Why?
|
Antigens, Protozoan | 1 | 2008 | 316 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5769 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2928 | 0.060 |
Why?
|
Patient Care Team | 1 | 2016 | 2521 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26125 | 0.060 |
Why?
|
Mucous Membrane | 1 | 2008 | 659 | 0.060 |
Why?
|
Urochordata | 1 | 2004 | 19 | 0.060 |
Why?
|
Biopsy | 1 | 2016 | 6766 | 0.060 |
Why?
|
Metamorphosis, Biological | 1 | 2004 | 37 | 0.060 |
Why?
|
Child | 5 | 2023 | 80153 | 0.060 |
Why?
|
RNA, Viral | 1 | 2012 | 2846 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6346 | 0.050 |
Why?
|
Health Personnel | 1 | 2017 | 3335 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3249 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10194 | 0.050 |
Why?
|
Blotting, Western | 1 | 2010 | 5035 | 0.050 |
Why?
|
Referral and Consultation | 3 | 2021 | 3600 | 0.050 |
Why?
|
Growth Substances | 1 | 2004 | 768 | 0.050 |
Why?
|
Protozoan Proteins | 1 | 2008 | 847 | 0.050 |
Why?
|
Prone Position | 1 | 2022 | 196 | 0.050 |
Why?
|
Middle Aged | 5 | 2020 | 220895 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2004 | 701 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2669 | 0.050 |
Why?
|
Hospitalization | 2 | 2018 | 10723 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8654 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6845 | 0.050 |
Why?
|
Gram-Positive Bacteria | 1 | 2021 | 177 | 0.040 |
Why?
|
Lactobacillus | 1 | 2021 | 212 | 0.040 |
Why?
|
Trophoblasts | 1 | 2021 | 224 | 0.040 |
Why?
|
Risk Factors | 4 | 2023 | 74206 | 0.040 |
Why?
|
Malaria, Falciparum | 1 | 2008 | 1077 | 0.040 |
Why?
|
Africa | 1 | 2021 | 709 | 0.040 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2021 | 343 | 0.040 |
Why?
|
Biodiversity | 1 | 2021 | 347 | 0.040 |
Why?
|
Edema | 1 | 2022 | 766 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 583 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2023 | 22176 | 0.040 |
Why?
|
Enterobacteriaceae | 1 | 2019 | 161 | 0.040 |
Why?
|
Acute Disease | 1 | 2008 | 7237 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20570 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2019 | 304 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1039 | 0.040 |
Why?
|
Liberia | 1 | 2017 | 174 | 0.030 |
Why?
|
Sierra Leone | 1 | 2017 | 169 | 0.030 |
Why?
|
Sputum | 1 | 2019 | 506 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 636 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1842 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14666 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1322 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1937 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2707 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1863 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2021 | 1048 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4575 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.030 |
Why?
|
United States | 2 | 2023 | 72334 | 0.030 |
Why?
|
Vaginal Douching | 1 | 2012 | 17 | 0.030 |
Why?
|
Program Evaluation | 1 | 2021 | 2495 | 0.030 |
Why?
|
Developing Countries | 1 | 2023 | 2885 | 0.020 |
Why?
|
Animals | 4 | 2020 | 168459 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 64680 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10773 | 0.020 |
Why?
|
Child, Preschool | 2 | 2008 | 42230 | 0.020 |
Why?
|
Aged | 1 | 2021 | 169289 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3882 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 80636 | 0.020 |
Why?
|
Endemic Diseases | 1 | 2008 | 190 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2850 | 0.020 |
Why?
|
Disease Progression | 2 | 2012 | 13506 | 0.010 |
Why?
|
Microscopy | 1 | 2008 | 903 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15266 | 0.010 |
Why?
|
Morphogenesis | 1 | 2004 | 741 | 0.010 |
Why?
|
Body Patterning | 1 | 2004 | 632 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1756 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29625 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3778 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81525 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3612 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7594 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39967 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9420 | 0.000 |
Why?
|
Signal Transduction | 1 | 2004 | 23445 | 0.000 |
Why?
|
Concepts
(248)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_